Nishida J - Search Results

1

Heterogenous expression of endoglin marks advanced renal cancer with distinct tumor microenvironment fitness.

Momoi Y, Nishida J, Miyakuni K, Kuroda M, Kubota SI, Miyazono K, Ehata S. Momoi Y, et al. Among authors: nishida j. Cancer Sci. 2021 Aug;112(8):3136-3149. doi: 10.1111/cas.15007. Epub 2021 Jun 28. Cancer Sci. 2021. PMID: 34091990 Free PMC article.

2

Decreased TGFBR3/betaglycan expression enhances the metastatic abilities of renal cell carcinoma cells through TGF-β-dependent and -independent mechanisms.

Nishida J, Miyazono K, Ehata S. Nishida J, et al. Oncogene. 2018 Apr;37(16):2197-2212. doi: 10.1038/s41388-017-0084-0. Epub 2018 Feb 2. Oncogene. 2018. PMID: 29391598 Free PMC article.

3

Epigenetic remodelling shapes inflammatory renal cancer and neutrophil-dependent metastasis.

Nishida J, Momoi Y, Miyakuni K, Tamura Y, Takahashi K, Koinuma D, Miyazono K, Ehata S. Nishida J, et al. Nat Cell Biol. 2020 Apr;22(4):465-475. doi: 10.1038/s41556-020-0491-2. Epub 2020 Mar 23. Nat Cell Biol. 2020. PMID: 32203421

4

Genome-wide analysis of DNA methylation identifies the apoptosis-related gene UQCRH as a tumor suppressor in renal cancer.

Miyakuni K, Nishida J, Koinuma D, Nagae G, Aburatani H, Miyazono K, Ehata S. Miyakuni K, et al. Among authors: nishida j. Mol Oncol. 2022 Feb;16(3):732-749. doi: 10.1002/1878-0261.13040. Epub 2021 Jul 5. Mol Oncol. 2022. PMID: 34133843 Free PMC article.

5

An in vivo orthotopic serial passaging model for a metastatic renal cancer study.

Nishida J, Miyakuni K, Miyazono K, Ehata S. Nishida J, et al. STAR Protoc. 2022 Apr 18;3(2):101306. doi: 10.1016/j.xpro.2022.101306. eCollection 2022 Jun 17. STAR Protoc. 2022. PMID: 35496785 Free PMC article.

6

Smad4 Decreases the Population of Pancreatic Cancer-Initiating Cells through Transcriptional Repression of ALDH1A1.

Hoshino Y, Nishida J, Katsuno Y, Koinuma D, Aoki T, Kokudo N, Miyazono K, Ehata S. Hoshino Y, et al. Among authors: nishida j. Am J Pathol. 2015 May;185(5):1457-70. doi: 10.1016/j.ajpath.2015.01.011. Epub 2015 Mar 11. Am J Pathol. 2015. PMID: 25769430 Free article.

7

ZEB1-regulated inflammatory phenotype in breast cancer cells.

Katsura A, Tamura Y, Hokari S, Harada M, Morikawa M, Sakurai T, Takahashi K, Mizutani A, Nishida J, Yokoyama Y, Morishita Y, Murakami T, Ehata S, Miyazono K, Koinuma D. Katsura A, et al. Among authors: nishida j. Mol Oncol. 2017 Sep;11(9):1241-1262. doi: 10.1002/1878-0261.12098. Epub 2017 Jul 11. Mol Oncol. 2017. PMID: 28618162 Free PMC article.

8

Whole-Body Profiling of Cancer Metastasis with Single-Cell Resolution.

Kubota SI, Takahashi K, Nishida J, Morishita Y, Ehata S, Tainaka K, Miyazono K, Ueda HR. Kubota SI, et al. Among authors: nishida j. Cell Rep. 2017 Jul 5;20(1):236-250. doi: 10.1016/j.celrep.2017.06.010. Cell Rep. 2017. PMID: 28683317 Free article.

9

Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis.

Raja E, Morikawa M, Nishida J, Tanabe R, Takahashi K, Seeherman HJ, Saito N, Todo T, Miyazono K. Raja E, et al. Among authors: nishida j. Cancer Sci. 2019 Nov;110(11):3486-3496. doi: 10.1111/cas.14187. Epub 2019 Sep 20. Cancer Sci. 2019. PMID: 31483918 Free PMC article.

10

Efficacy of an orally active small-molecule inhibitor of RANKL in bone metastasis.

Nakai Y, Okamoto K, Terashima A, Ehata S, Nishida J, Imamura T, Ono T, Takayanagi H. Nakai Y, et al. Among authors: nishida j. Bone Res. 2019 Jan 3;7:1. doi: 10.1038/s41413-018-0036-5. eCollection 2019. Bone Res. 2019. PMID: 30622830 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

425 results

Search Page